Long-term outcomes from a phase 1 dose escalation study using stereotactic body radiotherapy for patients with low- or intermediate-risk prostate cancer Journal Article


Authors: Moore, A.; Kollmeier, M. A.; McBride, S. M.; Toumbacaris, N.; Zhang, Z.; Lacy-Elsayegh, A.; Dreyfuss, A.; Grossman, C. E.; Gorovets, D.; Zelefsky, M. J.
Article Title: Long-term outcomes from a phase 1 dose escalation study using stereotactic body radiotherapy for patients with low- or intermediate-risk prostate cancer
Journal Title: European Urology Oncology
Volume: 7
Issue: 4
ISSN: 2588-9311
Publisher: Elsevier BV  
Date Published: 2024-08-01
Start Page: 812
End Page: 820
Language: English
PUBMED: 37949730
DOI: 10.1016/j.euo.2023.10.019
PROVIDER: manual
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Zhigang Zhang
    427 Zhang
  2. Michael J Zelefsky
    754 Zelefsky
  3. Marisa A Kollmeier
    227 Kollmeier
  4. Sean Matthew McBride
    293 McBride
  5. Assaf Moore
    10 Moore